TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 2 | 13 | 19 | 37 | 18 | -7 | 14 |
| S | %wins | 67 | 33 | 33 | 33 | 67 | 33 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/28/11 14:18 | 11/23/11 | PGNX | Progenics Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | S | -3 | 5.45 | 1 | -1 | -2 | 38 | D | 24 | 0 | -36 | -15 | -22 | -19 | -18 | -13 | 9 | 39 | 73 | 94 | 79 | -58 |
6/24/10 10:20 | 6/22/10 | PGNX | Progenics Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | P | S | -13 | 5.66 | 1 | -2 | -8 | 27 | D | -68 | 9 | 23 | 1 | -13 | -4 | -16 | -12 | 0 | 3 | -19 | -4 | -10 | 30 |
3/18/10 15:53 | 3/18/10 | PGNX | Progenics Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | P | S | -12 | 5.33 | 1 | -2 | -7 | 28 | D | 3 | -4 | 1 | 32 | 22 | 19 | 15 | 1 | -2 | -2 | 4 | 20 | -16 | 7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |